World Psoriasis Day

Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hungary, India, Indonesia, Ireland, Israel, Italy, Japan, Kenya, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Pakistan, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, Ukraine, United Arab Emirates, United Kingdom, United States

About

World Psoriasis Day, observed on October 29, raises awareness of psoriasis, a chronic condition that affects the skin and can also impact overall well-being. The day helps educate the public, challenge misconceptions, and highlight that psoriasis is not contagious.

It is also an opportunity to stand with people living with psoriasis and recognize the importance of understanding, support, and access to appropriate care. Through conversations, educational efforts, and acts of compassion, World Psoriasis Day encourages greater acceptance and reminds everyone that people with psoriasis deserve to be seen beyond their symptoms.

History

World Psoriasis Day is observed annually on **October 29** to raise awareness of psoriasis and psoriatic arthritis, chronic inflammatory conditions that affect millions of people worldwide. The observance was established in 2004 through the efforts of the International Federation of Psoriasis Associations (IFPA) and its member organizations. Its creation gave patient groups, health professionals, and advocates a shared occasion to explain the medical nature of psoriasis and to challenge the mistaken belief that it is contagious.

From its beginnings, the day has focused on giving people with psoriasis a stronger public voice. National and regional organizations have used October 29 for educational campaigns, public discussions, media outreach, screening and information events, and advocacy for better diagnosis and treatment. These activities are intended not only to increase general knowledge but also to encourage people experiencing symptoms to seek appropriate medical care rather than rely on misinformation or conceal their condition.

Over time, World Psoriasis Day has developed from a primarily awareness-based initiative into a broader international platform for patient rights and health-policy advocacy. Campaigns commonly address the psychological effects of visible skin disease, the stigma and discrimination many patients face, the importance of treating related conditions, and unequal access to specialist care and effective therapies. Attention has also increasingly included psoriatic arthritis, which can cause pain and lasting joint damage and may occur alongside skin symptoms.

Culturally, World Psoriasis Day represents a shift toward understanding psoriasis as a serious, manageable health condition rather than a cosmetic problem or a personal failing. Its annual observance on October 29 helps connect local patient communities across countries and reinforces the value of empathy, accurate information, and inclusive healthcare. By placing patients’ experiences at the center of public conversation, the day continues to support greater recognition and improved quality of life for people living with psoriasis and psoriatic arthritis.

Timeline

1841
Austrian dermatologist Ferdinand von Hebra helped establish psoriasis as a disease distinct from leprosy, correcting a longstanding clinical confusion in dermatology.
2004
The U.S. Food and Drug Administration approved alefacept (Amevive) for adults with moderate-to-severe chronic plaque psoriasis; it was the first biologic treatment approved for psoriasis in the United States.
2009
The U.S. Food and Drug Administration approved ustekinumab (Stelara) for adults with moderate-to-severe plaque psoriasis, adding an interleukin-12/23-targeting biologic treatment option.

Upcoming dates

Sources

Same day

Related